How Big Is Bristol Myers Squibb's Latest FDA Approval?

How Big Is Bristol Myers Squibb's Latest FDA Approval?

Source: 
Motley Fool
snippet: 

Bristol Myers Squibb (NYSE:BMY) recently picked up another U.S. Food and Drug Administration (FDA) approval for Zeposia in treating ulcerative colitis. In this Motley Fool Live video recorded on June 2, Motley Fool contributors Keith Speights and Brian Orelli discuss just how big this FDA win is for Bristol Myers Squibb.